EHMT2 and cancer: H3K9 methylation and its methyltransferase G9a are also considered as a prominent mechanism in cancer cell biology and a potential therapeutic target in cancer treatment (Casciello et al., 2015; Janardhan et al., 2018; Cao et al., 2019; Monaghan et al., 2019).